11-valent recombinant HPV vaccine (Hansenula polymorpha)

11-valent recombinant human papillomavirus vaccine · National Vaccine and Serum Institute, China

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 11-valent recombinant HPV vaccine (Hansenula polymorpha), covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years [Phase 3]

See pricing